Drug shortages homepage

Welcome to Drug Shortages Canada, the website for mandatory reporting of drug shortages and discontinuations by market authorization holders. Anyone can search the database of shortage and discontinuation reports. More information can be found on the About & Resources Page.

Early reporting of shortages and discontinuations provides Health Canada, provincial/territorial governments, drug supply chain stakeholders, and health professionals details needed to help them monitor and manage supply. Shortages can be caused by many factors. Some last longer and are more complex than others. Because companies have to report every time they cannot fully meet demand, not all of the reports on this site are cause for concern at the patient level. Most are successfully managed before they impact patients.

The shortage database has a flag that indicates ones that are Tier 3 drug shortages, which are those that could potentially have the highest impact on Canada's drug supply and health care system. A Tier 3 designation is decided by the Tier Assignment Committee (TAC), composed of federal and provincial/territorial governments, healthcare professionals, and industry stakeholders.

Ensuring people can get the medicines they need is a top priority for Health Canada. Health Canada works closely with many partners to prevent shortages, mitigate their impacts, and help resolve them when they occur.

If you would like to know more about shortages like why they happen, how long they last, the actions being taken to reduce impacts on Canadians, and actions you can take if a drug you use is in shortage, please consult the information on Canada.ca.

Below are the newest shortage and discontinuation reports and updates to existing ones.

Drug pills

LEGEND

!!T3 denotes an actual Tier 3 shortage/discontinuation

!T3 denotes an anticipated Tier 3 shortage/discontinuation

Shortage Reports

Brand name Company Name Status Strength Update Date Updated View Report
POTASSIUM CHLORIDE FOR INJECTION CONCENTRATE OMEGA LABORATORIES LIMITED Actual shortage 200mEq Updated Report 2024-11-06 240180
XARELTO BAYER INC Anticipated shortage 103.4MG New Report 2024-11-06 242145
ZOLMITRIPTAN ODT SANIS HEALTH INC Actual shortage 2.5MG Updated Report 2024-11-06 197629
ZOLMITRIPTAN SANIS HEALTH INC Actual shortage 2.5MG Updated Report 2024-11-06 224794
VALACYCLOVIR SANIS HEALTH INC Actual shortage 500MG Updated Report 2024-11-06 220653
DEPO-MEDROL 80 MG/ML PFIZER CANADA ULC Anticipated shortage 80MG New Report 2024-11-06 242131
ADVAIR 100 DISKUS GLAXOSMITHKLINE INC Resolved 100MCG 50MCG Updated Report 2024-11-06 239741
MYLAN-NAPROXEN/ESOMEPRAZOLE MR MYLAN PHARMACEUTICALS ULC Anticipated shortage 20MG 375MG New Report 2024-11-06 242126
CREON MINIMICROSPHERES 10 BGP PHARMA ULC Resolved 730UNIT 11200UNIT 10000UNIT Updated Report 2024-11-06 239643
SERTRALINE SANIS HEALTH INC Actual shortage 100MG Updated Report 2024-11-06 233530

Discontinuation Reports

Brand name Company Name Status Strength Update Date Updated View Report
GAVRETO HOFFMANN-LA ROCHE LIMITED To be discontinued 100MG New Report 2024-11-06 242142
AERMONY RESPICLICK TEVA CANADA LIMITED Discontinued 55MCG New Report 2024-11-05 242101
DORZOLAMIDE AND TIMOLOL EYE DROPS BP HIKMA CANADA LIMITED Discontinued 5MG 20MG New Report 2024-11-01 241852
PEDIACEL SANOFI PASTEUR LIMITED Discontinued 5MCG 20MCG 30MCG 10MCG 26UNIT 7UNIT 29UNIT 5LF 15LF 20MCG 3MCG New Report 2024-11-01 241815
DALACIN C 300 MG PFIZER CANADA ULC Discontinued 300MG Updated Report 2024-10-30 241493